Form 8-K - Current report:
SEC Accession No. 0001683168-24-003923
Filing Date
2024-05-31
Accepted
2024-05-31 16:30:11
Documents
15
Period of Report
2024-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mosaic_8k.htm   iXBRL 8-K 28638
5 EMPLOYMENT STATUS CHANGE LETTER DATED MAY 31, 2024 mosaic_ex1001.htm EX-10.1 8980
6 GRAPHIC image_002.jpg GRAPHIC 4754
  Complete submission text file 0001683168-24-003923.txt   213334

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cpmv-20240531.xsd EX-101.SCH 3015
3 XBRL LABEL FILE cpmv-20240531_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cpmv-20240531_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT mosaic_8k_htm.xml XML 3240
Mailing Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646
Business Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

EIN.: 841070278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22182 | Film No.: 241010214
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)